| Address: | 500 W Office Center Dr, Fort Washington, PA 19034, USA |
|---|---|
| Postal code: | 19034 |
| Phone: | (250) 744-2487 |
| Website: | https://www.auriniapharma.com/contact |
There are no reviews yet!
You can review this Business and help others by leaving a comment. If you want to share your thoughts about Aurinia Pharmaceuticals Inc, use the form below and your opinion, advice or comment will appear in this space.
At Aurinia Pharmaceuticals, we're developing innovative products for patients living with debilitating diseases. Aurinia Closes US$191.7 Million Public Offering of Common Shares and Full Exercise of Underwriters' Option to Purchase Additional Common Shares.
Aurinia Pharmaceuticals Inc., a clinical stage biopharmaceutical company, engages in the research, development, and commercialization of therapeutic drugs for the treatment of various diseases in the United States and China. Aurinia Pharmaceuticals Inc. is headquartered in Victoria, Canada.
Get today's Aurinia Pharmaceuticals Inc stock price and latest AUPH news as well as Aurinia Pharma real-time stock quotes, technical This is the main Aurinia Pharmaceuticals Inc stock chart and current price. You can find more details by going to one of the sections under this page such as...
Aurinia Pharmaceuticals Inc., a clinical stage biopharmaceutical company, engages in the research, development, and commercialization of therapeutic drugs for the treatment of various diseases in the United States and China. The company is involved in developing voclosporin...
AURINIA PHARMACEUTICALS INC : Company profile, business summary, shareholders, managers, financial ratings, industry, sector and market information Aurinia Pharmaceuticals, Inc. 4464 Markham Street Suite 1203 Victoria, BC V8Z 7X8. Phone : +1.250.744.2487 Fax : +1.250.744.2498...
Why Aurinia Pharmaceuticals Stock Soared 12.2% Today. Aurinia Closes US$191.7 Million Public Offering of Common Shares and Full Exercise of Underwriters' Option to Purchase Additional Common Shares.
Aurinia Pharmaceuticals Inc. is a Canada-based clinical-stage biopharmaceutical company operating in the field of nephrology and autoimmunity. The Company's primary business is the development of a therapeutic drug to treat autoimmune diseases, in particular lupus nephritis (LN).
Aurinia Pharmaceuticals Inc, a clinical stage biopharmaceutical company, engages in the research, development, and commercialization of therapeutic drugs for the treatment of various diseases in the United States and China. The company is involved in developing voclosporin, an investigational drug...
CONTACT: Aurinia Pharmaceuticals Investors: Celia Economides Head of IR & Communications ceconomides@auriniapharma.com or Media: Christopher Hippolyte Christopher.hippolyte@inventivhealth.com.
Aurinia Pharmaceuticals Inc is a biopharmaceutical company. It provides products for patients suffering from serious diseases with a high un... Teplephone: +1 250 708-4272. Address: 4464 Markham Street, Victoria V8Z 7X8, BC, CAN.